How to make CAR-T cell therapies for cancer safer and more effective
Researchers are installing safety switches and adding other features to the immune therapy
CAR-T 2.0 An immune therapy for cancer using CAR-T cells (two shown in yellow, attacking a breast cancer cell) made a big splash in 2017, but it comes with serious side effects that researchers are trying to combat.
Eye of Science/Science Source
This article is only available to Science News subscribers.
Subscribers, enter your e-mail address to access our archives.
